RENAGADE Trademark

Trademark Overview

On Wednesday, February 24, 2021, a trademark application was filed for RENAGADE with the United States Patent and Trademark Office. The USPTO has given the RENAGADE trademark a serial number of 90545046. The federal status of this trademark filing is REGISTERED as of Tuesday, January 31, 2023. This trademark is owned by Renagade Therapeutics LLC. The RENAGADE trademark is filed in the Chemical Products category with the following description:

Biochemical preparations for scientific purposes; Nucleic acid for laboratory use; Reagents for research purposes; Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in the biochemical and chemical industry; Reagents for scientific or medical research use
renagade

General Information

Serial Number90545046
Word MarkRENAGADE
Filing DateWednesday, February 24, 2021
Status700 - REGISTERED
Status DateTuesday, January 31, 2023
Registration Number6969702
Registration DateTuesday, January 31, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2022

Trademark Statements

Goods and ServicesBiochemical preparations for scientific purposes; Nucleic acid for laboratory use; Reagents for research purposes; Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in the biochemical and chemical industry; Reagents for scientific or medical research use

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, May 26, 2021
Primary Code001
First Use Anywhere DateWednesday, November 16, 2022
First Use In Commerce DateWednesday, November 16, 2022

Trademark Owner History

Party NameRenagade Therapeutics LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWatertown, MA 02472
Party NameRenagade Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142
Party NameRenagade Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Saturday, February 27, 2021NEW APPLICATION ENTERED
Wednesday, May 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 15, 2021ASSIGNED TO EXAMINER
Wednesday, September 15, 2021NON-FINAL ACTION WRITTEN
Wednesday, September 15, 2021NON-FINAL ACTION E-MAILED
Wednesday, September 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 29, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, March 29, 2022PETITION TO REVIVE-GRANTED
Tuesday, March 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 29, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, March 29, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, March 30, 2022NOTICE OF REVIVAL - E-MAILED
Thursday, March 31, 2022ASSIGNED TO LIE
Thursday, March 31, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 31, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 1, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, April 1, 2022EXAMINERS AMENDMENT E-MAILED
Friday, April 1, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 1, 2022EXAMINER'S AMENDMENT ENTERED
Friday, April 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 10, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 13, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 13, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 16, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, November 16, 2022USE AMENDMENT FILED
Monday, December 5, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 12, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 13, 2022SU - NON-FINAL ACTION - WRITTEN
Tuesday, December 13, 2022NON-FINAL ACTION E-MAILED
Tuesday, December 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 23, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, December 24, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 31, 2023REGISTERED-PRINCIPAL REGISTER
Friday, September 13, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

renagade disorders scientific research reagents chemical purposes vitro vivo biochemicals biochemical